메뉴 건너뛰기




Volumn 35, Issue 1-2, 2008, Pages 72-78

Advances in the treatments of systemic vasculitides

Author keywords

Advances; Systemic vasculitides; Treatment

Indexed keywords

15 DEOXYSPERGUALIN; ABATACEPT; ALPHA2B INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LAMIVUDINE; LEFLUNOMIDE; MEPOLIZUMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; PLACEBO; PREDNISONE; RESLIZUMAB; RIBAVIRIN; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VIDARABINE; MONOCLONAL ANTIBODY;

EID: 55249100790     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8068-4     Document Type: Review
Times cited : (8)

References (64)
  • 52
    • 12544253745 scopus 로고    scopus 로고
    • Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    • Wegener's Granulomatosis Etanercept Trial (WGET) Research Group 2005 N Engl J Med 352 351 361
    • (2005) N Engl J Med , vol.352 , pp. 351-361


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.